As the country heads into the respiratory illness season, the US Food and Drug Administration (FDA) announced yesterday its marketing authorization of the first over-the-counter (OTC) rapid-antigen ...
Each year, 100,000 older US adults and 58,000 infants and children younger than 5 years are hospitalized for RSV, and 6,000 and 100 or more, respectively, die of their infections, Centers for Disease ...